CA2323076A1 - Chondrosarcoma associated genes - Google Patents

Chondrosarcoma associated genes Download PDF

Info

Publication number
CA2323076A1
CA2323076A1 CA002323076A CA2323076A CA2323076A1 CA 2323076 A1 CA2323076 A1 CA 2323076A1 CA 002323076 A CA002323076 A CA 002323076A CA 2323076 A CA2323076 A CA 2323076A CA 2323076 A1 CA2323076 A1 CA 2323076A1
Authority
CA
Canada
Prior art keywords
csa
polypeptide
expression
chondrosarcoma
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002323076A
Other languages
English (en)
French (fr)
Inventor
Richard M. Terek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhode Island Hospital
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2323076A1 publication Critical patent/CA2323076A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57595—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving intracellular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
CA002323076A 1998-03-13 1999-03-12 Chondrosarcoma associated genes Abandoned CA2323076A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/042,225 1998-03-13
US09/042,225 US6207812B1 (en) 1998-03-13 1998-03-13 Chondrosarcoma associated genes
PCT/US1999/005348 WO1999046382A1 (en) 1998-03-13 1999-03-12 Chondrosarcoma associated genes

Publications (1)

Publication Number Publication Date
CA2323076A1 true CA2323076A1 (en) 1999-09-16

Family

ID=21920744

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002323076A Abandoned CA2323076A1 (en) 1998-03-13 1999-03-12 Chondrosarcoma associated genes

Country Status (11)

Country Link
US (2) US6207812B1 (https=)
EP (1) EP1062333B1 (https=)
JP (1) JP2002506617A (https=)
AT (1) ATE408686T1 (https=)
AU (1) AU762987B2 (https=)
CA (1) CA2323076A1 (https=)
DE (1) DE69939583D1 (https=)
DK (1) DK1062333T3 (https=)
ES (1) ES2317690T3 (https=)
PT (1) PT1062333E (https=)
WO (1) WO1999046382A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010003371A (es) 2007-09-28 2010-05-05 Intrexon Corp Constructos interruptores genicos terapeuticos y biorreactores para la expresion de moleculas bioterapeuticas y usos de los mismos.
KR102181548B1 (ko) * 2019-02-20 2020-11-20 한국외국어대학교 연구산학협력단 염증성 질환 또는 자가면역성 질환의 예방 또는 치료 활성을 갖는 펩타이드 및 이의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US5175385A (en) 1987-09-03 1992-12-29 Ohio University/Edison Animal Biotechnolgy Center Virus-resistant transgenic mice
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
US5350835A (en) * 1991-11-05 1994-09-27 Board Of Regents, University Of Texas Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids
US5744343A (en) * 1994-01-04 1998-04-28 Mitotix, Inc. Ubiquitin conjugating enzymes
US5612455A (en) * 1994-07-05 1997-03-18 Tularik, Inc. Nuclear factors and binding assay

Also Published As

Publication number Publication date
US6207812B1 (en) 2001-03-27
JP2002506617A (ja) 2002-03-05
AU762987B2 (en) 2003-07-10
DE69939583D1 (de) 2008-10-30
WO1999046382A1 (en) 1999-09-16
US20010016649A1 (en) 2001-08-23
AU2904099A (en) 1999-09-27
US7211646B2 (en) 2007-05-01
DK1062333T3 (da) 2009-01-26
ES2317690T3 (es) 2009-04-16
PT1062333E (pt) 2008-12-24
EP1062333B1 (en) 2008-09-17
EP1062333A1 (en) 2000-12-27
ATE408686T1 (de) 2008-10-15

Similar Documents

Publication Publication Date Title
US20100184023A1 (en) Prostate Specific Gene, PCGEM1, and Methods of Using PCGEM1 to Detect, Treat, and Prevent Prostate Cancer
EP1194549A2 (en) Human genes and gene expression products
JPH11510393A (ja) 白血病マーカーとしておよび乳癌の予後において有用な単離された核酸分子
EP1263956A2 (en) Human genes and gene expression products
JP2004512029A (ja) ヒト遺伝子および遺伝子発現産物
EP1086218A2 (en) Genes and gene expression products that are differentially regulated in prostate cancer
CN1964986A (zh) 用于鉴定、评价、预防和治疗卵巢癌的核酸分子和蛋白质
WO2006014999A2 (en) Compositions and methods of use for modulators of nectin 4, semaphorin 4b, igsf9, and kiaa0152 in treating disease
AU746135B2 (en) PARG, a GTPase activating protein which interacts with PTPL1
JP4190291B2 (ja) 癌細胞の増殖を調節するのに有用なポリヌクレオチド
US6361948B1 (en) Prognostic compositions for prostate cancer and methods of use thereof
US7211646B2 (en) Chondrosarcoma associated genes
EP1179589A1 (en) MMX-1, a member of the family of human cancer/testis antigens, a protein encoded thereby and a process for determining whether a tumor sample has metastatic potential
US7276587B2 (en) Antibodies to EGFH2 polypeptides
US6333403B1 (en) Chromosome 17p-linked prostate cancer susceptibility gene and a paralog and orthologous genes
CN100365021C (zh) 核蛋白“Shoca”-一种wnt信号传导途径的成分
EP1466988A2 (en) Genes and gene expression products that are differentially regulated in prostate cancer
AU2006200373B2 (en) Novel tumor supressor encoding nucleic acid, PTX1, and methods of use thereof
WO2000036420A2 (en) Differential expression in primary breast cancer
KR20020013477A (ko) 염색체 17ｐ 연관된 전립선암 감수성 유전자
Liang United States Patent te
WO2001025489A2 (en) Diagnostic and therapeutic uses for a gene differentially expressed in prostate cancer

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued